TNF Blocker Drugs and Children

Links shared publicly online about this topic

TNF blockers may increase the risk of malignancy in children

physorg.com — “The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor a (TNF) blockers, raising concerns of an associated risk and prompting an investigation. Researchers from the FDA set out to identify all reports of malignancy in children using infliximab, ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on July 29, 2010 at 8:40 pm By:

physorg_health PhysOrg Health News Health News

TNF blockers may increase the risk of malignancy in children http://tw.physorg.com/199639725

2 years ago...

TNF blockers may increase the risk of malignancy in children | e! Science News

esciencenews.com — “The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor a (TNF) blockers, raising concerns of an associated risk and prompting an investigation. Researchers from the FDA set out to identify all reports of malignancy in children using infliximab, etanercept, and adalimumab and their report is published in the August issue of Arthritis & Rheumatism , a journal of the American College of Rheumatology.View full resource at esciencenews.com

  • View Related
  • Share

Most Recently Shared on August 2, 2010 at 3:02 pm By:

InfusionNurse Infusion Nurse Nurse and Advanced Practice Nurse

TNF blockers may increase the risk of malignancy in children http://esciencenews.com/node/346701

2 years ago...

Malignancies in children linked to TNF blockers - ONA

oncologynurseadvisor.com — “Children using tumor necrosis factor-alpha (TNF) blockers may experience an increase risk of malignancy, according to an investigation conducted by researchers from the FDA.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on August 20, 2010 at 11:11 am By:

FDA Issues Warning for Some Juvenile Rheumatoid Arthritis Drugs - TNF Blockers May Boost Kids' Cancer Risk

spineuniverse.com — “The US Food and Drug Administration (FDA)announced that TNF blockers, a class of drugs commonly used to treat juvenile rheumatoid arthritis and ankylosing spondylitis, may increase the risk of cancer in children and young adults.View full resource at spineuniverse.com

  • View Related
  • Share

Most Recently Shared on August 12, 2009 at 8:16 pm By:

SpineUniverse SpineUniverse Health Site

FDA warns about TNF blockers for juvenile rheumatoid arthritis--but how concerned should you be? http://bit.ly/JhWnp

3 years ago...

Additional tumor necrosis factor (TNF) blocker analysis information - MPR

empr.com — “The FDA notified healthcare professionals on August 4, 2009 that it had completed its analysis of tumor necrosis factor (TNF) blockers and concluded that there is an increased risk of lymphoma and other cancers associated with the use of these drugs in children and adolescents.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on September 1, 2009 at 3:40 pm By:

eMPR MPR Medical Publisher

MPR News: Additional tumor necrosis factor (TNF) blocker analysis information: The FDA notified healthc.. http://bit.ly/704OW

3 years ago...

FDA finds more blood cancer with TNF blocker drugs | Reuters

reuters.com — “WASHINGTON (Reuters) - U.S. health regulators have received more reports of rare blood cancer in young patients taking a class of anti-inflammatory drugs used to treat digestive disorders.The drugs,View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 14, 2011 at 9:24 pm By:

MedicalNews Medical News Health News

FDA finds more blood cancer with TNF blocker drugs http://bit.ly/gNyhZE

1 year ago...

FDA finds more blood cancer with TNF blocker drugs | Reuters

reuters.com — “WASHINGTON (Reuters) - U.S. health regulators have received more reports of rare blood cancer in young patients taking a class of anti-inflammatory drugs used to treat digestive disorders.The drugs,View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 14, 2011 at 8:41 pm By:

FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi)

drugs.com — “FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi)View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 5, 2009 at 1:04 am By:

drugscom Drugs.com Health Site

FDA Alert - FDA Warns Tumor Necrosis Factor (TNF) Blockers May Increase Cancer Risk - http://bit.ly/xqXMR

3 years ago...

Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)

fda.gov — “Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on August 5, 2009 at 4:45 pm By:

SpineUniverse SpineUniverse Health Site

FDA warns of possible connection between drugs for inflammatory disorders and cancer in kids: http://bit.ly/BvQDV

3 years ago...

FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) August 2009

drugs.com — “FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) August 2009View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 31, 2009 at 8:40 pm By:

drugscom Drugs.com Health Site

FDA Alert - Update: FDA Warns Tumor Necrosis Factor (TNF) Blockers May Increase Cancer Risk - http://bit.ly/SB68Y

3 years ago...

Medical News: FDA Warns of Pediatric Cancer Risk with TNF Blockers - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA called for stronger warnings in prescribing information for tumor necrosis factor (TNF) blockers to highlight a greater risk of cancer in children and adolescents.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 4, 2009 at 11:15 pm By:

FightCancer FightCancer Health News

FDA Warns of Pediatric Cancer Risk with TNF Blockers http://bit.ly/1W651D

3 years ago...

Medical News: FDA Warns of New Infections With TNF Blockers - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “The Food and Drug Administration has updated the boxed warning for all tumor necrosis factor-alpha inhibiting drugs to reflect the risk of infection from the bacteria Legionella and ListeView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 7, 2011 at 9:03 pm By:

MedicalNews Medical News Health News

FDA Warns of New Infections With TNF Blockers http://t.co/mmlNrvF

9 months ago...

Medical News: FDA Warns of New Infections With TNF Blockers - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “The Food and Drug Administration has updated the boxed warning for all tumor necrosis factor-alpha inhibiting drugs to reflect the risk of infection from the bacteria Legionella and ListeView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 15, 2011 at 10:53 pm By:

FDA Drug Safety Communication: Drug labels for the Tumor Necrosis Factor-alpha (TNFα) blockers now include warnings about infection with Legionella and Listeria bacteria

fda.gov — “[9-07-2011] The U.S. Food and Drug Administration (FDA) is informing healthcare professionals that the Boxed Warning for the entire class of Tumor Necrosis Factor-alpha (TNFα) blockers has been updated to include the risk of infection from two bacterial pathogens, Legionella and Listeria.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on September 7, 2011 at 6:57 pm By:

FiercePharma FiercePharma Health Site

RT @aliciaault: FDA updates boxed warnings for TNF-alpha class w/risk of Legionella and Listeria http://t.co/qXEqMcV

9 months ago...

SAFETY ALERT: TNF-alpha Blockers' Boxed Warning Updated to Include Risk of Infection - MPR

empr.com — “The FDA has notified healthcare professionals that the Boxed Warning for the tumor necrosis factor-alpha (TNF-alpha) blocker class of drugs has been updated to include the risk of infection from Legionella and Listeria.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on September 7, 2011 at 7:24 pm By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390